All filters
E-Posters
Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement - Robert Ehret
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine - Zahedul Islam
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Sensitivity of ultra-deep sequencing for dual HIV infection detection - Darya Saleeva
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples - Andreas Chrysostomou
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico. - Luis Del Carpio-Orantes
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
PK-virological algorithm to target risk of resistance among key populations in Togo - Valentine Ferré
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020 - Marcel Schuetze
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
DRAWING: Children, Adolescents and Two Deadly Viruses | Lucie Cluver, MD
Presented at:
AIDSImpact 2021 | Webinar Series
E-Posters
DRAWING: Moving to mHealth – HIV and Future Care | Jenny Whetham, MD
Presented at:
AIDSImpact 2021 | Webinar Series
E-Posters
DRAWING: What Is Known About COVID-19 Incidence & Outcomes Among Those Living With HIV | Caroline Sabin, PhD
Presented at:
AIDSImpact 2021 | Webinar Series
E-Posters
DRAWING: Will COVID-19 Change Global Policy Regarding HIV? | Michel Kazatchkine, MD
Presented at:
AIDSImpact 2021 | Webinar Series
E-Posters
Breaking Bad: Chems, Sex And Sexual Health
M. Reiriz Rojas
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine
E. Gasich
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Using Next-Generation Sequencing To Assess The Differences In HIV Drug Resistance Pre- And Post-Treatment In A Treatment As Prevention Trial
S. Kemp
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Association Of Viral Reservoir With HIV Infection Duration, Viral Load And CD4 Count
D. Kireev
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Creation Of An Italian HIV Dna Network For The Validation And Clinical Use Of HIV-1 DNA Quantification Assays
I. Vicenti
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Exploratory Evaluation For The Optimization Of Next Generation Sequencing HIV-1 Drug Resistance Outcomes Based On An In-House RNA Extraction Protocol
A. Orta-Resendiz
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Associations Between Vitamin D And Fibrosis, Genotype, Viral Load In Patients Having Chronic Hepatitis C
M. Nikolaichuk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Quantification Of HBeAg Levels Differ Among The Different Phases Of Hbv Infection, And Can Predict Therapeutic Outcome In The Setting Of Immunosuppression Driven Hbv Reactivation
L. Piermatteo
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Combined Use Of High-Sensitivity Serological And Virological Hbv Markers Can Make Better In Predicting The Occurrence Of HBV Reactivation And To Optimize Prophylaxis Duration In HBsAg-Negative/Anti-HBc-Positive Patients In The Context Of Oncohematological
M. Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Effectiveness Of The Application Of Serological Tests And Laboratory Indicators As Part Of Rita For The Detection Of Recent HIV Infection
A. Murzakova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Ibalizumab Shows In Vitro Activity Against Group A And Group B HIV-2 Clinical Isolates
C. Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
TDF Surveillance And Clinically Relevant Resistance In Spain: 2019 Update
F. García
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HCV Resistance Associated Variants Following Directly Acting Agent Therapy Failure- Real Life Data From Poland
M. Parczewski
Presented at:
European Meeting on HIV & Hepatitis 2020